Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions

Bywaters, 1971, Still's disease in the adult, Ann Rheum Dis, 30, 121, 10.1136/ard.30.2.121 Still, 1897, On a form of chronic joint disease in children, Med Chir Trans, 80 Yamaguchi, 1992, Preliminary criteria for classification of adult Still's disease, J Rheumatol, 19, 424 Masson, 1995, Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France, Rev Rhum Engl Ed, 62, 748 Esdaile, 1980, Adult Still's disease, Am J Med, 68, 825, 10.1016/0002-9343(80)90201-6 Cush, 1987, Adult-onset Still's disease. Clinical course and outcome, Arthritis Rheum, 30, 186, 10.1002/art.1780300209 Pouchot, 2008, Maladie de Still de l'adulte, vol. 1, 449 Sampalis, 1995, A controlled study of the long-term prognosis of adult Still's disease, Am J Med, 98, 384, 10.1016/S0002-9343(99)80318-0 Gerfaud-Valentin, 2014, Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients, Medicine (Baltimore), 93, 91, 10.1097/MD.0000000000000021 Pouchot, 1991, Adult Still's disease: manifestations, disease course, and outcome in 62 patients, Medicine (Baltimore), 70, 118, 10.1097/00005792-199103000-00004 Reginato, 1987, Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure, Semin Arthritis Rheum, 17, 39, 10.1016/0049-0172(87)90015-1 Wouters, 1986, Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases, Q J Med, 61, 1055 Ohta, 1987, Adult Still's disease: review of 228 cases from the literature, J Rheumatol, 14, 1139 Ohta, 1990, Adult Still's disease: a multicenter survey of Japanese patients, J Rheumatol, 17, 1058 Magadur-Joly, 1995, Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France, Ann Rheum Dis, 54, 587, 10.1136/ard.54.7.587 van de Putte, 1991, Adult-onset Still's disease, Baillieres Clin Rheumatol, 5, 263, 10.1016/S0950-3579(05)80283-3 Wakai, 1997, Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan, J Epidemiol, 7, 221, 10.2188/jea.7.221 Medsger, 1976, Carpal arthritis with ankylosis in late onset Still's disease, Arthritis Rheum, 19, 232, 10.1002/art.1780190216 Nguyen, 1997, Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature, J Rheumatol, 24, 592 Bruckle, 1992, Cerebral involvement in adult onset Still's disease, Clin Rheumatol, 11, 276, 10.1007/BF02207972 Denault, 1990, Meningoencephalitis and peripheral neuropathy complicating adult Still's disease, J Rheumatol, 17, 698 Van Hoeyweghen, 1993, Interstitial lung disease and adult-onset Still's disease, Clin Rheumatol, 12, 418, 10.1007/BF02231592 Hosaka, 1992, Adult Still's disease with myocarditis and peritonitis, Intern Med, 31, 812, 10.2169/internalmedicine.31.812 Sachs, 1990, Myocarditis in adult Still's disease, Int J Cardiol, 27, 377, 10.1016/0167-5273(90)90295-G Taillan, 1990, Non-infectious mitral endocarditis during Still's disease in adults. A case with histologic study of the endocardium, Ann Med Interne (Paris), 141, 78 Yang, 2008, Etanercept as a rescue agent in patient with adult onset Still's disease complicated with congestive heart failure, Rheumatol Int, 29, 95, 10.1007/s00296-008-0619-3 Park, 2004, Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A, J Korean Med Sci, 19, 137, 10.3346/jkms.2004.19.1.137 Boki, 1996, Thrombotic thrombocytopenic purpura in adult Still's disease, J Rheumatol, 23, 385 Diamond, 1997, Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G, J Nephrol, 10, 253 Serratrice, 2003, Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease, Am J Med, 115, 589, 10.1016/j.amjmed.2003.04.001 Wendling, 1991, Adult onset Still's disease and related renal amyloidosis, Ann Rheum Dis, 50, 257, 10.1136/ard.50.4.257 Uppal, 2007, Ten years of clinical experience with adult onset Still's disease: is the outcome improving?, Clin Rheumatol, 26, 1055, 10.1007/s10067-006-0440-x Dhote, 2003, Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review, Arthritis Rheum, 49, 633, 10.1002/art.11368 Hot, 2010, Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case–control study of 8 patients, Medicine (Baltimore), 89, 37, 10.1097/MD.0b013e3181caf100 Arlet, 2006, Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature, Ann Rheum Dis, 65, 1596, 10.1136/ard.2005.046904 Agarwal, 2011, A rare trigger for macrophage activation syndrome, Rheumatol Int, 31, 405, 10.1007/s00296-009-1204-0 Banse, 2013, Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease, Joint Bone Spine, 80, 653, 10.1016/j.jbspin.2013.04.011 Kobayashi, 2011, Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome, Mod Rheumatol, 21, 92, 10.3109/s10165-010-0348-9 Chen, 2009, Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease, Ann Rheum Dis, 68, 1074, 10.1136/ard.2008.098335 Fautrel, 2001, Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease, J Rheumatol, 28, 322 Olive, 1991, Ferritin and adult Still's disease, Br J Rheumatol, 30, 158, 10.1093/rheumatology/30.2.158 Coffernils, 1992, Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome, J Rheumatol, 19, 1425 Van Reeth, 1994, Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease, J Rheumatol, 21, 890 Zandman-Goddard, 2007, Ferritin in autoimmune diseases, Autoimmun Rev, 6, 457, 10.1016/j.autrev.2007.01.016 Lambotte, 2003, High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation, J Rheumatol, 30, 1027 Vignes, 2000, Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease, Ann Rheum Dis, 59, 347, 10.1136/ard.59.5.347 Fautrel, 2002, Proposal for a new set of classification criteria for adult-onset still disease, Medicine (Baltimore), 81, 194, 10.1097/00005792-200205000-00003 Larroche, 2004, Pathogenesis of hemophagocytic syndrome (HPS), Autoimmun Rev, 3, 69, 10.1016/S1568-9972(03)00091-0 Masson, 1996, Comparative study of 6 types of criteria in adult Still's disease, J Rheumatol, 23, 495 Jiang, 2011, Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population, J Rheumatol, 38, 741, 10.3899/jrheum.100766 Valente, 1989, Characterization of lymph node histology in adult onset Still's disease, J Rheumatol, 16, 349 Saghafi, 2013, Does searching for antineutrophil cytoplasmic antibodies help with the diagnosis of Adult-onset Still's disease?, Rheumatol Int, 33, 571, 10.1007/s00296-012-2377-5 Akkoc, 2008, Ankylosing spondylitis and spondylarthropathy presenting with a clinical picture of adult onset Still's disease: case series, Rheumatology (Oxford), 47, 1436, 10.1093/rheumatology/ken288 Valtonen, 1997, Serological findings in patients with acute syndromes fulfilling the proposed criteria of adult onset Still's disease, Scand J Rheumatol, 26, 342, 10.3109/03009749709065695 Zenagui, 1995, Atypical presentation of adult Still's disease mimicking acute bacterial endocarditis, Eur Heart J, 16, 1448, 10.1093/oxfordjournals.eurheartj.a060756 Wouters, 1988, Adult onset Still's disease and viral infections, Ann Rheum Dis, 47, 764, 10.1136/ard.47.9.764 Newkirk, 1993, Aberrant cellular localization of rubella viral genome in patients with adult Still's disease—a pilot study, Autoimmunity, 16, 39, 10.3109/08916939309010646 Pouchot, 1993, Adult Still's disease associated with acute human parvovirus B19 infection, Lancet, 341, 1280, 10.1016/0140-6736(93)91184-N Daibata, 2002, Human herpesvirus 6 and adult-onset Still's disease, Am J Med, 113, 532, 10.1016/S0002-9343(02)01238-X Sridharan, 2000, Hepatitis A infection mimicking adult onset Still's disease, J Rheumatol, 27, 1792 Balleari, 1991, Adult-onset Still's disease associated to toxoplasma gondii infection, Clin Rheumatol, 10, 326, 10.1007/BF02208701 Ahn, 2010, Adult onset Still's disease diagnosed concomitantly with occult papillary thyroid cancer: paraneoplastic manifestation or coincidence?, Clin Rheumatol, 29, 221, 10.1007/s10067-009-1305-x Drenth, 1995, Metastatic breast cancer presenting as fever, rash, and arthritis, Cancer, 75, 1608, 10.1002/1097-0142(19950401)75:7<1608::AID-CNCR2820750709>3.0.CO;2-A Rogues, 1993, Breast cancer with systemic manifestations mimicking Still's disease, J Rheumatol, 20, 1786 Trotta, 1993, Immunoblastic malignant lymphoma in adult onset Still's disease, J Rheumatol, 20, 1788 Liozon, 2014, Adult-onset Still's disease as a manifestation of malignancy: report of a patient with melanoma and literature review, Rev Med Interne, 35, 60, 10.1016/j.revmed.2013.02.014 Rosario, 2013, The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome, BMC Med, 11, 185, 10.1186/1741-7015-11-185 Hayem, 2009, Is Still's disease an autoinflammatory syndrome?, Joint Bone Spine, 76, 7, 10.1016/j.jbspin.2008.05.009 Rossi-Semerano, 2012, Is Still's disease an autoinflammatory syndrome?, Int J Inflamm, 2012, 480373, 10.1155/2012/480373 Merino, 2005, Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001), J Rheumatol, 32, 559 Prakken, 2011, Juvenile idiopathic arthritis, Lancet, 377, 2138, 10.1016/S0140-6736(11)60244-4 Lin, 2011, The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis, Autoimmun Rev, 10, 482, 10.1016/j.autrev.2011.02.001 Chen, 2004, Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease, J Rheumatol, 31, 2189 Fujii, 2001, Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease, Rheumatology (Oxford), 40, 1398, 10.1093/rheumatology/40.12.1398 Franchini, 2010, Adult onset Still's disease: clinical presentation in a large cohort of Italian patients, Clin Exp Rheumatol, 28, 41 Ichida, 2013, Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18, Arthritis Care Res (Hoboken), 66, 4 Antoniou, 2013, Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations, Case Rep Med, 2013, 981232, 10.1155/2013/981232 Efthimiou, 2012, Adult onset Still's disease and autoinflammation, Int J Inflamm, 2012, 964751, 10.1155/2012/964751 Fraisse, 2006, Evolution and prognosis of adult onset Still's disease. A monocentric study of 17 patients, Rev Med Interne, 27, 658, 10.1016/j.revmed.2006.05.003 Dino, 1996, Fulminant hepatic failure in adult onset Still's disease, J Rheumatol, 23, 784 Motoo, 1991, Adult-onset Still's disease: hepatic involvement and various serum markers relating to the disease activity, Jpn J Med, 30, 247, 10.2169/internalmedicine1962.30.247 Colina, 2009, Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation, Rheumatol Int, 29, 1355, 10.1007/s00296-008-0813-3 Gianella, 2008, Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome, Am J Hematol, 83, 424, 10.1002/ajh.21084 Franchini, 2010, Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease, Arthritis Rheum, 62, 2530, 10.1002/art.27532 Choi, 2003, Serum cytokine profiles in patients with adult onset Still's disease, J Rheumatol, 30, 2422 Ortiz-Sanjuan, 2014, Efficacy of tocilizumab in conventional treatment-refractory adult-onset still's disease: multicenter retrospective open-label study of thirty-four patients, Arthritis Rheumatol, 66, 1659, 10.1002/art.38398 Pouchot, 2012, Biological treatment in adult-onset Still's disease, Best Pract Res Clin Rheumatol, 26, 477, 10.1016/j.berh.2012.07.002 Kotter, 2007, Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature, Semin Arthritis Rheum, 37, 189, 10.1016/j.semarthrit.2007.04.002 Masters, 2009, Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*), Annu Rev Immunol, 27, 621, 10.1146/annurev.immunol.25.022106.141627 Jung, 2014, Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease, Scand J Rheumatol, 43, 162, 10.3109/03009742.2013.824023 Saiki, 2004, Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile, Clin Immunol, 112, 120, 10.1016/j.clim.2004.03.023 Chen, 2013, Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease, Arthritis Res Ther, 15, R39, 10.1186/ar4193 Hoshino, 1998, Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease, J Rheumatol, 25, 396 Matsui, 1999, High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease, Rheumatology (Oxford), 38, 477, 10.1093/rheumatology/38.5.477 Andres, 2003, Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities, Hepatogastroenterology, 50, 192 Min, 2003, Bone marrow findings in patients with adult Still's disease, Scand J Rheumatol, 32, 119, 10.1080/03009740310000148 Pascual, 2005, Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade, J Exp Med, 201, 1479, 10.1084/jem.20050473 Kalliolias, 2008, The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis, Expert Opin Investig Drugs, 17, 349, 10.1517/13543784.17.3.349 Scheinberg, 1996, Interleukin 6: a possible marker of disease activity in adult onset Still's disease, Clin Exp Rheumatol, 14, 653 Nishimoto, 2006, Interleukin 6: from bench to bedside, Nat Clin Pract Rheumatol, 2, 619, 10.1038/ncprheum0338 Zimmers, 2003, Massive liver growth in mice induced by systemic interleukin 6 administration, Hepatology, 38, 326, 10.1053/jhep.2003.50318 Mima, 2009, Clinical value of blocking IL-6 receptor, Curr Opin Rheumatol, 21, 224, 10.1097/BOR.0b013e3283295fec Kawaguchi, 2001, Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease, Arthritis Rheum, 44, 1716, 10.1002/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I Kawashima, 2001, Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease, Arthritis Rheum, 44, 550, 10.1002/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5 Priori, 2014, Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis, J Rheumatol, 41, 1118, 10.3899/jrheum.130575 Rooney, 2004, Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis, Ann Rheum Dis, 63, 1393, 10.1136/ard.2003.016428 Lotito, 2007, Interleukin-18 in chronic joint diseases, Autoimmun Rev, 6, 253, 10.1016/j.autrev.2006.08.010 Conigliaro, 2009, Lymph node IL-18 expression in adult-onset Still's disease, Ann Rheum Dis, 68, 442, 10.1136/ard.2008.093781 Priori, 2011, Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis, Rheumatology (Oxford), 50, 776, 10.1093/rheumatology/keq397 Ogata, 2003, Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease, J Rheumatol, 30, 1093 Sugiura, 2002, Association between adult-onset Still's disease and interleukin-18 gene polymorphisms, Genes Immun, 3, 394, 10.1038/sj.gene.6363922 Maruyama, 2010, Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases, J Rheumatol, 37, 967, 10.3899/jrheum.090662 Nagashima, 2012, Interleukin-18 in adult-onset Still's disease: treatment target or disease activity indicator?, Intern Med, 51, 449, 10.2169/internalmedicine.51.6678 Tsutsui, 1999, Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice, Immunity, 11, 359, 10.1016/S1074-7613(00)80111-9 Rau, 2010, Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis, J Rheumatol, 37, 2369, 10.3899/jrheum.100247 Kontzias, 2008, Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances, Drugs, 68, 319, 10.2165/00003495-200868030-00005 Cefle, 2005, Leflunomide and azathioprine combination in refractory adult-onset Still's disease, Ann Pharmacother, 39, 764, 10.1345/aph.1E425 Pirildar, 2003, Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients, Clin Rheumatol, 22, 157, 10.1007/s10067-002-0667-0 Fautrel, 1999, Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease, J Rheumatol, 26, 373 Permal, 1995, Treatment of Still disease in adults with intravenous immunoglobulins, Rev Med Interne, 16, 250, 10.1016/0248-8663(96)80703-X Vignes, 1999, Still's disease in adults: treatment with intravenous immunoglobulins, Rev Med Interne, 20, 419s, 10.1016/S0248-8663(00)88672-5 Al-Homood, 2014, Biologic treatments for adult-onset Still's disease, Rheumatology (Oxford), 53, 32, 10.1093/rheumatology/ket250 Fautrel, 2005, Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases, Ann Rheum Dis, 64, 262, 10.1136/ard.2004.024026 Husni, 2002, Etanercept in the treatment of adult patients with Still's disease, Arthritis Rheum, 46, 1171, 10.1002/art.10231 Bruck, 2011, Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids, J Clin Rheumatol, 17, 23, 10.1097/RHU.0b013e318205092d Laskari, 2011, Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study, Arthritis Res Ther, 13, R91, 10.1186/ar3366 Lequerre, 2008, Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France, Ann Rheum Dis, 67, 302, 10.1136/ard.2007.076034 Nordstrom, 2012, Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study, J Rheumatol, 39, 2008, 10.3899/jrheum.111549 Lo Gullo AC, 2014, Canakinumab in a case of Adult onset Still's disease: efficacy only on systemic manifestations, Joint Bone Spine, 81, 376, 10.1016/j.jbspin.2013.12.011 Suematsu, 2012, Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan, Mod Rheumatol, 22, 712, 10.3109/s10165-011-0569-6 Bonilla Hernan, 2004, Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases, An Med Interna, 21, 23 Caramaschi, 2002, A case of adult onset Still's disease treated with infliximab, Clin Exp Rheumatol, 20, 113 Huffstutter, 2004, Treatment of resistant adult still disease with infliximab: a report of 2 cases, J Clin Rheumatol, 10, 218, 10.1097/01.rhu.0000135618.25723.16 Olivieri, 2003, Infliximab in a case of early adult-onset Still's disease, Clin Rheumatol, 22, 369, 10.1007/s10067-003-0744-z Cavagna, 2001, Infliximab in the treatment of adult Still's disease refractory to conventional therapy, Clin Exp Rheumatol, 19, 329 Dilhuydy, 2005, Prolonged efficacy of infliximab for refractory adult-onset Still's disease, Clin Exp Rheumatol, 23, 121 Kokkinos, 2004, Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients, Clin Rheumatol, 23, 45, 10.1007/s10067-003-0775-5 Kraetsch, 2001, Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences, Ann Rheum Dis, 60, iii55 Aeberli, 2002, Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders, Swiss Med Wkly, 132, 414 Benucci, 2005, Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report, Clin Exp Rheumatol, 23, 733 Kumari, 2006, Prolonged remission in adult-onset Still's disease with etanercept, Clin Rheumatol, 25, 106, 10.1007/s10067-004-1064-7 Aikawa, 2011, Is anti-TNF switching in refractory Still's disease safe and effective?, Clin Rheumatol, 30, 1129, 10.1007/s10067-011-1735-0 Hedrich, 2012, Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA), Rheumatol Int, 32, 3525, 10.1007/s00296-011-2249-4 Fitzgerald, 2005, Rapid responses to anakinra in patients with refractory adult-onset Still's disease, Arthritis Rheum, 52, 1794, 10.1002/art.21061 Giampietro, 2013, Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy, Arthritis Care Res (Hoboken), 65, 822, 10.1002/acr.21901 Kahn, 2013, Higher-dose anakinra is effective in a case of medically refractory macrophage activation syndrome, J Rheumatol, 40, 743, 10.3899/jrheum.121098 Kalliolias, 2007, Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial, Ann Rheum Dis, 66, 842, 10.1136/ard.2006.066381 Kontzias, 2012, The use of Canakinumab, a novel IL-1beta long-acting inhibitor, in refractory adult-onset Still's disease, Semin Arthritis Rheum, 42, 201, 10.1016/j.semarthrit.2012.03.004 Lahiri, 2010, A case of refractory adult-onset Still's disease treated with anakinra, Int J Rheum Dis, 13, e36, 10.1111/j.1756-185X.2010.01474.x Loh, 2012, Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra, Intern Med J, 42, 1358, 10.1111/imj.12002 Naumann, 2010, IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease, Ann Rheum Dis, 69, 466, 10.1136/ard.2009.108068 Petryna, 2012, IL-1 Trap rilonacept in refractory adult onset Still's disease, Ann Rheum Dis, 71, 2056, 10.1136/annrheumdis-2012-201409 Gattorno, 2008, The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis, Arthritis Rheum, 58, 1505, 10.1002/art.23437 Ruperto, 2012, Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis, N Engl J Med, 367, 2396, 10.1056/NEJMoa1205099 Ruperto, 2012, A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features, Arthritis Rheum, 64, 557, 10.1002/art.33342 Kone-Paut, 2012, Targeting interleukin-1beta in CAPS (cryopyrin-associated periodic) syndromes: what did we learn?, Autoimmun Rev, 12, 77, 10.1016/j.autrev.2012.07.026 Bannai, 2014, Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease, Mod Rheumatol, 10.3109/14397595.2014.899178 De Bandt, 2009, Tocilizumab for multirefractory adult-onset Still's disease, Ann Rheum Dis, 68, 153, 10.1136/ard.2008.088179 de Boysson, 2013, Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence, Clin Rheumatol, 32, 141, 10.1007/s10067-012-2105-2 Kadavath, 2014, A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6, Int J Rheum Dis, 17, 336, 10.1111/1756-185X.12324 Kishida, 2011, Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis, Mod Rheumatol, 21, 215, 10.3109/s10165-010-0365-8 Matsumoto, 2009, Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab, Clin Rheumatol, 28, 485, 10.1007/s10067-009-1097-z Nakahara, 2009, A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6years, Mod Rheumatol, 19, 69, 10.3109/s10165-008-0116-2 Perdan-Pirkmajer, 2010, A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature, Clin Rheumatol, 29, 1465, 10.1007/s10067-010-1553-9 Rkiouak, 2012, Adult refractory Still disease with atypical articular manifestations: efficacity of interleukin-6 antagonists (tocilizumab), Ann Pharm Fr, 70, 163, 10.1016/j.pharma.2012.03.001 Sabnis, 2011, Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis—efficacy of interleukin-6 blockade and review of the literature, Semin Arthritis Rheum, 40, 365, 10.1016/j.semarthrit.2010.05.003 Sakai, 2012, Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review, Clin Rheumatol, 31, 569, 10.1007/s10067-011-1917-9 Savage, 2014, Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab, Rheumatology (Oxford), 53, 1352, 10.1093/rheumatology/keu019 Sumida, 2010, Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab, Clin Rheumatol, 29, 1191, 10.1007/s10067-010-1418-2 Thonhofer, 2011, Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature, Rheumatol Int, 31, 1653, 10.1007/s00296-010-1631-y Yoshimura, 2010, Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD), Clin Exp Rheumatol, 28, 141 Cipriani, 2014, Tocilizumab for the treatment of adult-onset Still's disease: results from a case series, Clin Rheumatol, 33, 49, 10.1007/s10067-013-2381-5 Elkayam, 2014, Tocilizumab in adult-onset Still's disease: the Israeli experience, J Rheumatol, 41, 244, 10.3899/jrheum.130881 Puechal, 2011, Tocilizumab in refractory adult Still's disease, Arthritis Care Res (Hoboken), 63, 155, 10.1002/acr.20319 Genovese, 2008, Arthritis Rheum, 58, 2968, 10.1002/art.23940 Smolen, 2008, Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial, Lancet, 371, 987, 10.1016/S0140-6736(08)60453-5 De Benedetti, 2012, Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis, N Engl J Med, 367, 2385, 10.1056/NEJMoa1112802 Youssef, 2008, Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes, J Rheumatol, 35, 2453, 10.3899/jrheum.080150